Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Number of holders
-
203
-
Total 13F shares, excl. options
-
54,786,766
-
Shares change
-
-688,166
-
Total reported value, excl. options
-
$2,458,102,091
-
Value change
-
-$29,442,951
-
Number of buys
-
105
-
Number of sells
-
-87
-
Price
-
$44.87
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2017
219 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q3 2017.
HAEMONETICS CORP - Common Stock (HAE) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,786,766 shares
.
Largest 10 shareholders include BlackRock Inc. (6,445,828 shares), VANGUARD GROUP INC (4,885,262 shares), WELLINGTON MANAGEMENT GROUP LLP (4,360,204 shares), WELLS FARGO & COMPANY/MN (2,759,457 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,604,262 shares), VICTORY CAPITAL MANAGEMENT INC (2,414,526 shares), Neuberger Berman Group LLC (2,053,458 shares), FULLER & THALER ASSET MANAGEMENT, INC. (1,829,273 shares), DIMENSIONAL FUND ADVISORS LP (1,742,281 shares), and HealthCor Management, L.P. (1,452,343 shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.